Circulation, Vol 76, 15-20, Copyright © 1987 by American Heart Association
C Rainer, DT Kawanishi, PA Chandraratna, RM Bauersachs, CL Reid, SH Rahimtoola and HJ Meiselman
We investigated several rheologic variables in 17 patients (11 men, six
women, mean age = 52.1 +/- 9.8 years) with chronic stable angina. None took
any medication except for sublingual nitroglycerin for 2 weeks before the
study, and all had angiographically proven coronary artery disease with no
history of myocardial infarction. Rheologic measurements included
hematocrit, whole blood and plasma viscosity (750 and 1500 sec-1), degree
of red cell aggregation via the zeta sedimentation ratio, and the extent
and rate of red cell aggregation after stasis (Myrenne aggregometer).
Compared with normal control donors, salient observations in the patients
as a group included: a small (6%) but significant increase in hematocrit, a
significant elevation in plasma viscosity (9%), significant increases in
whole blood viscosity at both shear rates (14% and 16%), significant
increases in the degree (12%), the extent (41%), and the rate (28% faster
time constant) of red cell aggregation, an elevated alpha 2 level (15%
increase) and a significantly increased fibrinogen concentration (25%
increase), both of which correlated with the enhanced red cell aggregation.
Rheologic abnormalities were evident when patients with disease in either
one vessel or two to three vessels were compared with controls, but
differences between these subgroups of patients were not significant. We
conclude that patients with angina have rheologic abnormalities that are
compatible with disturbed blood flow and an enhanced tendency for coronary
arterial thrombosis.
ARTICLES
Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease
This article has been cited by other articles:
![]() |
I. Levin, R. Gamzu, Y. Hasson, J.B. Lessing, A. Amit, I. Shapira, S. Berliner, and B. Almog Increased erythrocyte aggregation in ovarian hyperstimulation syndrome: a possible contributing factor in the pathophysiology of this disease Hum. Reprod., May 1, 2004; 19(5): 1076 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamath and G.Y.H. Lip Fibrinogen: biochemistry, epidemiology and determinants QJM, October 1, 2003; 96(10): 711 - 729. [Full Text] [PDF] |
||||
![]() |
E. D. Crouch and L. E. Watson Intravenous Immunoglobulin-Related Acute Coronary Syndrome and Coronary Angiography in Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review Angiology, January 1, 2002; 53(1): 113 - 117. [Abstract] [PDF] |
||||
![]() |
R. B. Ami, G. Barshtein, D. Zeltser, Y. Goldberg, I. Shapira, A. Roth, G. Keren, H. Miller, V. Prochorov, A. Eldor, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1982 - H1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides The Genesis of Atherosclerosis and Risk Factors: A Review Angiology, February 1, 2001; 52(2): 89 - 98. [Abstract] [PDF] |
||||
![]() |
F.B Smith, F.G.R Fowkes, A Rumley, A.J Lee, G.D.O Lowe, and C.M Hau Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study Eur. Heart J., October 1, 2000; 21(19): 1607 - 1613. [Abstract] [PDF] |
||||
![]() |
O. Elkayam, D. Paran, R. Milo, Y. Davidovitz, D. Almoznino-Sarafian, D. Zeltser, M. Yaron, and D. Caspi Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases Ann Rheum Dis, January 1, 2000; 59(1): 77 - 77. [Abstract] [Full Text] |
||||
![]() |
R. Junker, J. Heinrich, H. Ulbrich, H. Schulte, R. Schonfeld, E. Kohler, and G. Assmann Relationship Between Plasma Viscosity and the Severity of Coronary Heart Disease Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Poredos and B. Zizek Plasma Viscosity Increase with Progression of Peripheral Arterial Atherosclerotic Disease Angiology, March 1, 1996; 47(3): 253 - 259. [Abstract] [PDF] |
||||
![]() |
J. C. Barnett and R. C. Touchon Therapy of Ischemic Cardiomyopathy with Pentoxifylline Angiology, December 1, 1990; 41(12): 1048 - 1052. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |